Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013–2015)

Published 2018 View Full Article

Authors

Keywords

Ceftolozane/tazobactam, Drug resistance, Enterobacteriaceae, Pseudomonas aeruginosa, Asia-Pacific, Surveillance

Journal

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Volume 51, Issue 2, Pages 181-189

Publisher

Elsevier BV

Online

2017-10-12

DOI

10.1016/j.ijantimicag.2017.09.016

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More